Subscribe
We published 100 InvestorsChronicle of the Week last year – with some more than doubling in value
There’s no better way to diversify your income than with a discounted and reliable dividend payer
This Danish drug giant has suffered plenty of misfortune, but better times lie ahead
The managers strike the right balance between high payouts and making sure your capital grows too
Rate cuts and deregulation could bolster this bank that’s already punching above its weight
The company isn’t merely recovering – the main division is now worth more than the group itself
There are plenty of execution risks in its grand transformation plan
A couple of pivotal years should see the Swiss giant through its patent erosion
This trust is built to hold up well in a crisis
Poor sentiment and an unusual structure mean this rejuvenated media stock trades at an exceptionally low discount
